Inspired by Nature, Powered by Science, Advancing Human Wellness

Core Technologies

Our Current Patented and Proven Platforms, Ready for Widespread Application

Linebacker™

A platform employing small molecule X-bonded polyphenols to potentially improve potency, efficacy, bioavailability, and permeability of biopharmaceuticals, while ensuring safety and tolerability

Laetose™

A unique combination of multiple sugars that independently paired with inositol has potential to inhibit the inflammatory and metabolic response of sugar alone

3F™

Unique Formulation of botanical ingredients (e.g., terpenes) with demonstrated effect as an insect repellant and an antimicrobial

Equivir™

A novel FDA Generally Recognized as Safe (GRAS) eligible polyphenol blend with proven antiviral effects and potential applications as medication or supplements

Celios®

Celios® is an advanced air purification technology company committed to improving indoor air quality through patented filtration solutions. 

Pipeline

From discovery to delivery, explore our technologies at various stages of development

Meet Our Team

The driving force behind our success

Recent Updates

Impact Biomedical Inc. Announcement Stock Activity / Pricing

Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today..

Impact Biomedical Inc. Announces Acquisition of Celios®

Impact Biomedical Inc. Announces Acquisition of Celios®, “Protecting People, Plants, and Animals from the World’s Most Dangerous Pathogens With Clean-Room..

Impact BioMedical Inc. to Present at The Microcap Conference

Impact Biomedical Inc. today announced that Frank D. Heuszel, Chief Executive Officer, is pleased to announce his participation in The..